Related Experiment Video
Updated: Aug 6, 2025

21:16
An In Vitro Skin Irritation Test SIT using the EpiDerm Reconstructed Human Epidermal RHE Model
Published on: July 13, 2009
68.0K
Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology
Nicola Gilmour1, Nathalie Alépée2, Sebastian Hoffmann3
1Unilever, Colworth Science Park, Bedford, United Kingdom.
ALTEX
|March 15, 2023
Summary
New cosmetic safety assessments use New Approach Methodologies (NAMs) and Defined Approaches (DAs) to predict skin sensitization. This study refines the Next Generation Risk Assessment (NGRA) framework, showing DAs provide varied conclusions for leave-on products.
Area of Science:
- Cosmetic Science
- Toxicology
- Risk Assessment
Background:
- Regulatory bans on animal testing drive adoption of New Approach Methodologies (NAMs) like in silico, in chemico, and in vitro methods.
- Defined Approaches (DAs) integrate NAMs to assess skin sensitization hazard and potency, with some adopted by OECD Test Guideline 497.
- Deriving quantitative points of departure from DAs for Next Generation Risk Assessment (NGRA) remains a challenge.
Purpose of the Study:
- To update a previously published NGRA framework.
- To present hypothetical consumer risk assessment scenarios for rinse-off and leave-on products using a case study ingredient.
- To evaluate the use of DAs in deriving quantitative risk assessment conclusions.
Main Methods:
- Applied seven Defined Approaches (DAs) to Diethanolamine (DEA), a case study ingredient.
- Utilized existing NAM data for DEA, noting discrepancies between in silico predictions and in chemico/in vitro data.
- Conducted hypothetical risk assessments for rinse-off and leave-on consumer exposure scenarios.
Main Results:
- Divergent DA outcomes were observed due to discrepancies in NAM data for DEA, impacting confidence in hazard and potency predictions.
- Risk assessment concluded safety for rinse-off exposure across all applied DAs.
- Risk assessment for leave-on exposure yielded mixed conclusions: safe for some DAs, unsafe for others.
Conclusions:
- The study highlights the challenges in achieving consistent risk assessment conclusions with current DAs, particularly for leave-on products.
- Identified reasons for divergent outcomes and inherent uncertainties associated with NAMs and DAs.
- Provided insights for further refinement of the NGRA framework to enhance reliability and confidence in safety assessments.
Related Concept Videos
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
153
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
153

